Application of copper-manganese bimetal MOFs in catalytic degradation of sulfonamide antibiotics

By introducing copper-manganese bimetallic MOFs (CuMn-BDC nanosheets) into the water treatment catalyst, the problems of low efficiency and insufficient stability of existing catalysts are solved, and efficient degradation and stability improvement of sulfonamide antibiotics are achieved, which significantly improves the Catalytic properties and pollutant removal rate.

CN119076060AInactive Publication Date: 2024-12-06BEIJING INST OF TECH TANGSHAN RES INST +1
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411254078.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-09
Publication Date
2024-12-06
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing water treatment catalysts are inefficient and difficult to find a balance between catalytic performance and stability. The electron transfer rate and stability of traditional heterophasic Fenton catalysts affect the degradation effect of organic pollutants.

Method used

Using copper-manganese bimetallic MOFs (CuMn-BDC nanosheets) as catalyst, an efficient CuMn-BDC is prepared by doping Mn elements into a two-dimensional metal organic framework composed of Cu cluster-terephthalate linkage. The heterophasic Fenton catalyst uses Mn to enhance its catalytic performance without changing the self-coordination structure of Cu-BDC, forming a large number of hydroxyl radicals to degrade sulfonamide antibiotics.

Benefits of technology

CuMn-BDC nanosheets significantly improve the heterophasic Fenton catalytic performance. The removal rate of sulfamethoxazole by catalysts reaches 99.8% under the same conditions, and a large number of reactive oxygen species are generated in advanced oxidation systems, significantly improving pollutants. The degradation efficiency and stability are much higher than that of single metal catalysts.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119076060A_ABST
    Figure CN119076060A_ABST
Patent Text Reader

Abstract

The invention discloses application of copper-manganese bimetal MOFs in catalytic degradation of sulfonamide antibiotics, and relates to the technical field of metal organic framework water treatment. Mn in the CuMn-BDC nanosheets can greatly enhance the Fenton-like catalytic performance of Cu-BDC without affecting the coordination structure of Cu-BDC, effective decomposition of hydrogen peroxide is enhanced to form a large number of hydroxyl free radicals, the hydroxyl free radicals rapidly oxidize sulfamethoxazole, and the sulfamethoxazole is degraded and removed.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of metal organic framework water treatment, and in particular to application of copper-manganese bimetallic MOFs in catalytic degradation of sulfonamide antibiotics. Background Art

[0002] Homogeneous Fenton technology is a traditional method for treating organic pollutants. However, it is limited by Fe 3+ Due to the reduction rate limitation and the large amount of toxic iron sludge produced, it is extremely important to develop efficient heterogeneous Fenton-like catalysts. Traditional heterogeneous catalysts exhibit low Fenton-like activity due to the number of their own active sites and the low electron transfer rate inside the catalyst. The use of a second metal doping can effectively improve the catalytic activity of Fenton-like catalysts by adjusting the electronic structure, improving the electron transfer efficiency and improving the stability. Among many variable-valence transition metal catalysts, metal-organic frameworks (MOFs) have attracted increasing attention in heterogeneous catalytic oxidation systems due to their large specific surface area, abundant unsaturated metal sites and adjustable pore structure. However, in water treatment, the trade-off between catalytic performance and stability should be further studied to overcome the current problems of low catalyst efficiency.

[0003] Publication No. CN114011466A discloses an ultra-thin copper-manganese bimetallic MOFs denitration catalyst and its preparation method and application, and obtains a copper-manganese bimetallic MOFs material as a denitration catalyst to assist CO in reducing NOx, thereby achieving effective denitration. In this reaction, MOFs has the ability to selectively catalyze and reduce NOx with CO, which is significantly different from the properties and principles of active hydrogen peroxide in MOFs materials in water treatment and has no reference value. Summary of the invention

[0004] The present invention provides an application of copper-manganese bimetallic MOFs in the catalytic degradation of sulfonamide antibiotics. Mn element is doped into a two-dimensional metal organic framework composed of Cu clusters and terephthalate to prepare an efficient CuMn-BDC heterogeneous Fenton-like catalyst, thereby solving the problem of low efficiency of existing water treatment catalysts.

[0005] To achieve this technical purpose, the present invention adopts the following scheme: application of copper-manganese bimetallic MOFs in catalytic degradation of sulfonamide antibiotics, and the copper-manganese bimetallic MOFs are CuMn-BDC nanosheets.

[0006] Furthermore, the sulfonamide antibiotic is any one or more of sulfamethoxazole, sulfadiazine, sulfamethoxazole, and sulfamethoxazole.

[0007] Compared with the prior art, the beneficial effects of the present invention are as follows: Mn in the CuMn-BDC nanosheets can greatly enhance the heterogeneous Fenton-like catalytic performance of Cu-BDC without affecting its own coordination structure, strengthen the effective decomposition of hydrogen peroxide to form a large number of hydroxyl radicals, and the hydroxyl radicals quickly oxidize sulfamethoxazole to achieve its degradation and removal.

[0008] Furthermore, the CuMn-BDC nanosheets were added to 50 mL of sulfamethoxazole solution with a concentration of 10 mg / L and dispersed using ultrasound and a magnetic stirrer at 450 rpm until they were uniformly dispersed; then 16 mmol / L of H2O2 was added to induce a Fenton-like reaction at room temperature.

[0009] Furthermore, the preparation process of CuMn-BDC nanosheets is as follows: N,N-dimethylformamide, ethanol and water are mixed to obtain a mixed solution; then, 1,4-phthalic acid is ultrasonically dissolved into the mixed solution, and then copper salt and manganese salt are added to dissolve, triethylamine is quickly injected, and stirring is continued to obtain a product solution; finally, the product solution is centrifuged to obtain a solid product, which is washed with ethanol and vacuum dried to obtain a copper-manganese bimetallic two-dimensional metal-organic framework nanosheet.

[0010] Furthermore, the volume ratio of N,N-dimethylformamide:ethanol:water is 7:1:1.

[0011] Furthermore, the copper salt is CuCl2·2H2O, and the manganese salt is MnCl2·4H2O.

[0012] Further, the molar ratio of 1,4-phthalic acid:CuCl2·2H2O:MnCl2·4H2O is 2:1:1.

[0013] Further, the usage ratio of N,N-dimethylformamide:ethanol:water:1,4-phthalic acid:CuCl2·2H2O:MnCl2·4H2O:triethylamine is 42mL:6mL:6mL:1.5mmol:0.75mmol:0.75 mmol:1.6 mL.

[0014] Furthermore, the stirring time was continued for 24 h and the vacuum drying temperature was 60 °C.

[0015] Furthermore, using N,N-dimethylformamide as solvent, the copper-manganese bimetallic two-dimensional metal-organic framework nanosheets as filler and catalyst, polyvinyl pyrrolidone as hydrophilic improver, and polyvinylidene fluoride membrane as membrane matrix, a one-pot method is adopted to synthesize the casting solution, and a mixed matrix membrane is obtained by a scraping machine, and the mixed matrix membrane is used for Fenton degradation of sulfonamide antibiotics. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1The scanning electron microscope image (1a) and the electron spectrometer scanning image (1b) of different elements of the CuMn-BDC nanosheet prepared by the present invention; Figure 2 The diffraction peak diagrams of powder crystals of the three products of CuMn-BDC, Cu-BDC and Mn-BDC provided by the present invention, the vertical coordinates of the three curves are set in equal proportion; Figure 3 The Fenton-like degradation curves of the three products of CuMn-BDC, Cu-BDC and Mn-BDC provided by the present invention on sulfamethoxazole; Figure 4 A bar graph showing the mineralization performance of the three products CuMn-BDC, Cu-BDC and Mn-BDC provided by the present invention on sulfamethoxazole; Figure 5 The Fenton-like degradation curve of CuMn-BDC provided by the present invention to sulfamethoxazole, diclofenac and ibuprofen, wherein k represents the reaction rate; Figure 6 The cyclic voltammetry curves of Cu-BDC and CuMn-BDC provided by the present invention, wherein E o represents the oxidation peak potential, E R represents the reduction peak potential, Figure 6 Medium E o1 and E R1 Represents the data on the CuMn-BDC cyclic voltammetry curve, E o2 and E R2 Represents the data on the Cu-BDC cyclic voltammetry curve; Figure 7 A free radical capture curve diagram of the CuMn-BDC / H2O2 advanced oxidation system provided by the present invention; Figure 8 The electron spin resonance signal generated by superoxide radicals of the three products of CuMn-BDC, Cu-BDC and Mn-BDC provided by the present invention; Fig. 9 The electron spin resonance signal generated by hydroxyl radicals of the three products of CuMn-BDC, Cu-BDC and Mn-BDC provided by the present invention; Fig.10 The test results of different water quality permeability of the mixed matrix membrane provided by the present invention and the suction filtration comparison membranes 1-3; Fig.11 The degradation ability of the mixed matrix membrane provided by the present invention and the filtration comparison membrane 2 in treating sulfamethoxazole simulated waste liquid and the monitoring results of manganese ion metal leaching concentration are shown. DETAILED DESCRIPTION

[0017] In order to fully understand the purpose, features and effects of the present invention, the present invention is described in detail through the following specific implementation methods, but the present invention is not limited thereto.

[0018] Preparation of CuMn-BDC: 42 mL of N,N-dimethylformamide (DMF), 6 mL of ethanol, and 6 mL of water were mixed in a 100 mL wide-mouth reagent bottle. Subsequently, 1.5 mmol of 1,4-benzenedicarboxylic acid was ultrasonically dissolved in the mixed solution. Next, 0.75 mmol of CuCl2·2H2O and 0.75 mmol of MnCl2·4H2O were added; after the metal salts were dissolved, 1.6 mL of triethylamine (TEA) was quickly injected and stirred for 24 h. Finally, the product was obtained by centrifugation (usually 10000 rpm for 1 min), washed three times with ethanol, and dried at 60 °C in vacuum to obtain the final product, which was labeled as CuMn-BDC.

[0019] Preparation of Cu-BDC: The preparation process is the same as that of CuMn-BDC, except that 0.75 mmol CuCl2·2H2O and 0.75 mmol MnCl2·4H2O are replaced by 1.5 mmol CuCl2·2H2O, and the obtained product is recorded as Cu-BDC.

[0020] Preparation of Mn-BDC: The preparation process is the same as that of CuMn-BDC, except that 0.75 mmol CuCl2·2H2O and 0.75 mmol MnCl2·4H2O are replaced by 1.5 mmol MnCl2·4H2O, and the obtained product is recorded as Mn-BDC.

[0021] The obtained CuMn-BDC metal organic framework nanosheets were scanned by an energy spectrometer, and the results are as follows Figure 1 As shown, the elements are evenly distributed, proving the successful introduction of Mn and Cu active sites.

[0022] X-ray diffraction tests were performed on CuMn-BDC, Cu-BDC and Mn-BDC, respectively. The results are as follows: Figure 2 As shown in Figure 2, the X-ray diffraction pattern shows that the crystallinity of Mn-BDC is lower, and its characteristic main peak has a significant shift compared with the other two. However, the introduction of Mn into the Cu-BDC structure does not cause obvious crystallinity loss and phase change. Figure 1 The semi-quantitative elemental analysis results obtained by medium energy spectrometer surface scanning showed that the contents of Cu and Mn were roughly equivalent, indicating that the bimetallic CuMn-BDC nanosheets inherited the crystal structure of Cu-BDC and the successful introduction of Mn.

[0023] Removal Example (SMX+CuMn-BDC+H2O2): SMX was used as a model pollutant to study the Fenton-like catalytic ability of CuMn-BDC nanosheets. 10 mg of CuMn-BDC nanosheets was added to 50 mL of SMX solution with a concentration of 10 mg / L, and dispersed using ultrasound (40kHz) and a magnetic stirrer at 450 rpm until the dispersion was uniform. Then 16 mmol / L of H2O2 was added to initiate a Fenton-like reaction at room temperature.

[0024] The sampling time was 0.25 min, 0.42 min, 58 min, 0.75 min, 1 min, 2 min, 3 min, 5 min, 7 min, 10 min, 15 min, and 20 min, respectively. 0.6 mL of the sample was taken each time and filtered through a 0.45 μm PTFE filter membrane before being placed in a brown liquid sample bottle for testing. The liquid sample was analyzed by Agilent 1260 liquid chromatograph, and the mobile phase flow rate was 0.5 mL / min (aqueous phase: containing 2 mM ammonium acetate and 0.1% formic acid, organic phase: aqueous phase = 0.6:0.4). The sample was quantitatively analyzed at a wavelength of 270 nm by passing through a chromatographic column (InfinityLab Poroshell 120 SB-C18, 4.6 mm × 150 mm, filler particle size 5 μm). The column temperature was 30 °C and the retention time was 6.2 min.

[0025] Removal of Comparative Example 1 (SMX+Cu-BDC+H2O2): The same process as in the above embodiment was adopted, only the CuMn-BDC nanosheets were replaced by Cu-BDC, and the other conditions were exactly the same.

[0026] Removal of Comparative Example 2 (SMX+Mn-BDC+H2O2): The same process as in the above embodiment was adopted, only the CuMn-BDC nanosheets were replaced by Mn-BDC, and the other conditions were exactly the same.

[0027] Removal of Comparative Example 3 (SMX+CuMn-BDC): The same process as in the above example, except that no hydrogen peroxide was added, was used to detect the adsorption performance of the CuMn-BDC nanosheets.

[0028] The degradation performance of sulfamethoxazole in Examples and Comparative Examples 1 to 3 is plotted as a curve. Figure 3 As shown, the mineralization performance (total organic carbon removal rate) of the samples taken at 20 minutes in the embodiments and comparative examples 1 to 2 is as follows Figure 4As shown. Within 20 minutes, the removal percentages were in the following order: CuMn-BDC (99.8%) > Cu-BDC (57.9%) > Mn-BDC (0.5%), and the corresponding total organic carbon (TOC) removal rates at 20 minutes were: CuMn-BDC (56.8%) > Cu-BDC (24.3%) > Mn-BDC (0.2%). This means that under the same experimental conditions, Mn-BDC is almost unable to activate hydrogen peroxide to degrade SMX; Cu II Due to its good catalytic performance and thermodynamic reaction rate, it can effectively degrade some pollutants. In contrast, the introduction of Mn greatly promotes the Fenton-like activity of the catalyst, thus showing the highest catalytic reaction rate and mineralization rate, playing a synergistic role. At 1 minute, the removal rates of SMX by Cu-BDC and CuMn-BDC were 47.2% and 71.7%, respectively. The removal rate of CuMn-BDC was about 1.52 times that of Cu-BDC. It can be seen that its improvement effect is far greater than the simple superposition of Cu-BDC and Mn-BDC, which has an unexpected technical effect.

[0029] Removal of comparative example 4 (DF+CuMn-BDC+H2O2): Same as Example, except that sulfamethoxazole (SMX) was replaced with diclofenac (DF) contaminant.

[0030] Removal of comparative example 5 (IBU+CuMn-BDC+H2O2): Same as Example 1, except that sulfamethoxazole (SMX) was replaced with ibuprofen (IBU) contaminant.

[0031] The degradation performance of the embodiment and comparative examples 4 to 5 is plotted as a curve. Figure 5 As shown in the figure, the degradation results show that there are huge differences in the degradation rates of different pollutants. Figure 5 The small figure in the upper right corner is the reaction rate diagram. The degradation rate of sulfamethoxazole by CuMn-BDC is significantly higher than that of diclofenac (DF) and ibuprofen (IBU), and it is selective for the type of antibiotics.

[0032] The electrochemical detection of CuMn-BDC and Cu-BDC was carried out by cyclic voltammetry. Figure 6 As shown in Figure 2. Mn doping increases the current density of the catalyst, which indicates that the relative number of active metal sites has been improved. Moreover, the spacing between the redox peaks of the bimetallic nanosheets is reduced compared to the single metal nanosheets, indicating that the cycling of metal valence states in the bimetallic system is more favorable from a thermodynamic point of view.

[0033] The free radical capture experiment was carried out on the CuMn-BDC / H2O2 advanced oxidation system in the embodiment using electron paramagnetic resonance spectroscopy technology. The active oxygen species that dominated the degradation of pollutants were determined by detecting the characteristic signals generated by the active oxygen species captured by the capture agent. The results are as follows: Figure 7 Hydroxyl radicals (DMPO-•OH) were observed in CuMn-BDC / H2O2 solutions with 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) (1:2:2:1, A N = A Hβ = 14.9 G) and alkyl radical (DMPO-•R) (1:1:1:1:1:1, A N = 16.0 G, A Hβ = 22.3 G) characteristic signal. Adding SMX to the solution can promote the generation of •OH, which indicates that the electrons of the electron-donating group of SMX directly activate H2O2 through CuMn-BDC nanosheets. This is consistent with the above Figure 5 The different oxidation rate trends caused by pollutants with different groups are consistent. In addition, a typical DMPO-O2•− characteristic signal (A Hβ = 10.9 G), and found that the very weak 1 O2-related characteristic signals (A N =17.1 G).

[0034] The signal intensity of electron spin resonance spectroscopy can semi-quantitatively detect the relative amount of reactive oxygen species in the advanced oxidation system. The three products of CuMn-BDC, Cu-BDC and Mn-BDC were tested by electron spin resonance spectroscopy. Figure 8 and Fig. 9 The free radical signal intensity generated by the system in which the bimetallic nanosheets participate is much higher than that corresponding to the single metal nanosheets, indicating that under the same amount of catalytic substrate, CuMn-BDC has more catalytic activity than Cu-BDC and Mn-BDC.

[0035] Scanning electron microscopy, electron spectrometer scanning and X-ray diffraction patterns prove that CuMn bimetallic organic framework nanosheets were successfully synthesized at room temperature. Mn can greatly enhance its Fenton-like catalytic performance without affecting the coordination structure of Cu-BDC itself, and strengthen the effective decomposition of hydrogen peroxide to form a large number of hydroxyl radicals. In addition, pollutants with electrophilic functional groups can be directly oxidized through electron transfer or transfer electrons to hydrogen peroxide to form more hydroxyl radicals to further promote the degradation of pollutants.

[0036] Mixed matrix membrane: 250 mg of polyvinyl pyrrolidone (PVP) was dissolved in 5 mL of N, N-dimethylformamide (DMF) in a 60°C oil bath, and then 250 mg of CuMn-BDC was added. After ultrasonic treatment for 60 min, it was placed in a 60°C oil bath and stirred for 60 min. Then 800 mg of polyvinylidene fluoride (PVDF) was added, and stirring continued for 3 h. Finally, it was scraped to a thickness of 300 nm and immersed in water overnight to complete the phase separation process, resulting in a mixed matrix membrane, denoted as MMM, with a catalyst loading of about 0.06 g.

[0037] Filtration comparison membrane 1 15 mg CuMn-BDC was mixed with 2 mL water, 15 mL ethanol and 100 μL Nafion perfluorosulfonic acid resin solution. After ultrasonic treatment for one hour, the mixture was directly filtered and deposited on a commercial hydrophilic PTFE membrane and dried at room temperature. It was recorded as P1.

[0038] Filtration comparison membrane 2 The amount of CuMn-BDC was changed to 25 mg, and the other operations were the same as those of the suction filtration comparison membrane 1, which was recorded as P2.

[0039] Filtration comparison membrane 3 The amount of CuMn-BDC was changed to 40 mg, and other operations were the same as those of the suction filtration comparison membrane 1, which was recorded as P3.

[0040] The pressure difference method was used to test the permeability of the mixed matrix membrane and the filtration comparison membranes 1-3 to pure water and tap water, and the data within 60 minutes were taken. The results are as follows: Fig.10 shown.

[0041] Fig.10 The water permeability of the four membranes under two different water qualities is shown. The water flux of P1, P2 and P3 in pure water is 2306, 1522 and 367 L / m 2 –h–bar, and in tap water they are 2088, 1377 and 314 L / m 2 –h–bar. The water flux of the mixed matrix membrane in pure water and tap water is 320 and 297 L / m 2 In order to further compare the Fenton-like catalytic ability and stability of different membranes, P2 and the prepared mixed matrix membrane (MMM) were selected for comparison.

[0042] P2 and MMM were subjected to a Fenton-like degradation experiment of 10 mg / L sulfamethoxazole simulated wastewater under a continuous flow system (1 mL / min). The reaction conditions were: membrane diameter 4.7 cm; H2O2 concentration = 16 mM, volume 100 mL; flow rate 1 mL / min; SMX initial concentration 10 mg / L; temperature 25°C; the catalyst loading of the P2 membrane was 25 mg, and the weight of the MMM membrane with a diameter of 4 cm was 0.24 g, of which the content of CuMn-BDC was 60 mg.

[0043] The results of the Fenton-like degradation experiment are as follows Fig.11 As shown in the figure, although P2 has good water flux, it cannot intercept sulfamethoxazole. P2 showed extremely high degradation performance from 0 to 60 min. However, its degradation ability declined after 60 min (only 93% at 60 min), which means that the catalyst directly loaded on the surface was partially decomposed. The large amount of manganese ion leaching (0.85 mg / L) also proves that the decomposition of the ligand leads to the exposure of more metal active sites, which in turn leads to severe leaching, far exceeding the drinking water Mn limit stipulated by the World Health Organization (WHO). 2+ Limiting concentration (0.5 g / L). In contrast, the catalyst loading in the mixed matrix membrane is higher, but the stability of the Fenton-like catalytic performance and the leaching amount of manganese ions are better than those directly loaded on the high water flux membrane. The degradation efficiency of pollutants did not decrease significantly within 60 min and always remained above 96%. 2+ The leached content is only half of that of P2.

[0044] The CuMn-BDC two-dimensional metal organic framework material was loaded in the PVDF organic matrix by casting solution scraping and phase separation to form a new type of mixed matrix membrane. Compared with the traditional direct deposition loading method, this new mixed matrix membrane can obtain higher water flux and catalyst loading. Moreover, compared with directly loading the catalyst on the high water flux PTFE membrane, the new mixed matrix membrane can achieve more stable catalytic efficiency and lower metal ion leaching.

[0045] Finally, it should be noted that the above are only preferred embodiments of the present invention. Of course, those skilled in the art can make changes and modifications to the present invention. If these modifications and variations fall within the scope of the claims of the present invention and their equivalent technologies, they should be considered to be within the scope of protection of the present invention.

Claims

1. Application of copper-manganese bimetallic MOFs in catalytic degradation of sulfonamide antibiotics, characterized in that: Copper-manganese bimetallic MOFs are CuMn-BDC nanosheets.

2. The use of the copper-manganese bimetallic MOFs in catalytic degradation of sulfonamide antibiotics according to claim 1, characterized in that: Sulfonamide antibiotics include any one or more of sulfamethoxazole, sulfadiazine, sulfamethoxazole, and sulfadimethoxine.

3. The use of the copper-manganese bimetallic MOFs in catalytic degradation of sulfamethoxazole according to claim 1, characterized in that: CuMn-BDC nanosheets were added into 50 mL of sulfamethoxazole solution with a concentration of 10 mg / L and dispersed using ultrasound and a magnetic stirrer at 450 rpm until the dispersion was uniform; Then 16mmol / L H2O2 was added to induce a Fenton-like reaction at room temperature.

4. The use of the copper-manganese bimetallic MOFs in catalytic degradation of sulfonamide antibiotics according to claim 1, characterized in that: Preparation process of CuMn-BDC nanosheets: N,N-dimethylformamide, ethanol and water are mixed to obtain a mixed solution; then, 1,4-phthalic acid is ultrasonically dissolved into the mixed solution, and then copper salt and manganese salt are added to dissolve, triethylamine is quickly injected, and stirring is continued to obtain a product solution; finally, the product solution is centrifuged to obtain a solid product, which is washed with ethanol and vacuum dried to obtain a copper-manganese bimetallic two-dimensional metal-organic framework nanosheet.

5. The use of the copper-manganese bimetallic MOFs in catalytic degradation of sulfonamide antibiotics according to claim 4, characterized in that: The volume ratio of N,N-dimethylformamide:ethanol:water is 7:1:

1.

6. The use of the copper-manganese bimetallic MOFs in catalytic degradation of sulfonamide antibiotics according to claim 4, characterized in that: The copper salt is CuCl2·2H2O and the manganese salt is MnCl2·4H2O.

7. The use of the copper-manganese bimetallic MOFs in catalytic degradation of sulfonamide antibiotics according to claim 6, characterized in that: The molar ratio of 1,4-phthalic acid:CuCl2·2H2O:MnCl2·4H2O is 2:1:

1.

8. The use of the copper-manganese bimetallic MOFs in catalytic degradation of sulfonamide antibiotics according to claim 6, characterized in that: The usage ratio of N,N-dimethylformamide:ethanol:water:1,4-phthalic acid:CuCl2·2H2O:MnCl2·4H2O:triethylamine is 42mL:6mL:6mL:1.5mmol:0.75mmol:0.75 mmol:1.6 mL.

9. The use of the copper-manganese bimetallic MOFs in catalytic degradation of sulfonamide antibiotics according to claim 4, characterized in that: The stirring time was continued for 24 h and the vacuum drying temperature was 60 °C.

10. The use of the copper-manganese bimetallic MOFs in catalytic degradation of sulfonamide antibiotics according to claim 4, characterized in that: N,N-dimethylformamide is used as a solvent, the copper-manganese bimetallic two-dimensional metal organic framework nanosheets are used as fillers and catalysts, polyvinyl pyrrolidone is used as a hydrophilic improver, and a polyvinylidene fluoride membrane is used as a membrane matrix. A one-pot method is adopted to synthesize a casting solution, and a membrane body is obtained by a scraping machine. Phase separation is performed in water to obtain a mixed matrix membrane, and the mixed matrix membrane is used to perform Fenton degradation of sulfonamide antibiotics.

Citation Information

Patent Citations

  • Ultrathin copper-manganese bimetallic MOFs denitration catalyst as well as preparation method and application thereof

    CN114011466A

  • Copper-manganese-doped iron metal organic framework material, preparation method thereof and method for treating organic wastewater by catalytically activating persulfate

    CN113351254A

  • Manganese-cobalt binary metal-based MOF adsorbent for removing NOx gas and preparation method thereof

    CN113578275A

  • Tri-metal carbon nanomaterial as well as preparation method and application thereof

    CN117899912A

  • Metal organic frameworks as catalysts and hydrocarbon oxidation methods thereof

    US20170326536A1